Jeffrey Weitz
McMaster University
H-index: 138
North America-Canada
Top articles of Jeffrey Weitz
Global Health Burden of Venous Thromboembolism
Arteriosclerosis, Thrombosis, and Vascular Biology
2024/5
Algorithm for Rapid Exclusion of Clinically Relevant Plasma Levels of Direct Oral Anticoagulants in Patients Using the DOAC Dipstick: An Expert Consensus Paper
Thrombosis and Haemostasis
2024/3/8
Current Gaps in the Provision of Safe and Effective Anticoagulation in Atrial Fibrillation and the Potential for Factor XI-Directed Therapeutics
2024/2/21
Anticoagulation with osocimab in patients with kidney failure undergoing hemodialysis: a randomized phase 2 trial
Nature Medicine
2024/2/16
Human platelets contain a pool of free zinc in dense granules
Research and Practice in Thrombosis and Haemostasis
2024/2/15
Direct oral anticoagulation versus warfarin in patients with atrial fibrillation and bioprosthetic heart valves: a retrospective, real-world cohort study
Cardiovascular Drugs and Therapy
2024/2
When Direct Oral Anticoagulants Should Not Be Standard Treatment: JACC State-of-the-Art Review
2024/1/23
Vascular closure devices and methods providing hemostatic enhancement
2024/1/16
Thrombin-activatable fibrinolysis inhibitor and sex modulate thrombus stability and pulmonary embolism burden in a murine model
Journal of Thrombosis and Haemostasis
2024/1/1
36-month clinical outcomes of patients with venous thromboembolism: GARFIELD-VTE
Thrombosis research
2023/2/1
Shinya Goto
H-Index: 51
Pantep Angchaisuksiri
H-Index: 24
Peter Verhamme
H-Index: 48
Hugo Ten Cate
H-Index: 52
Henri Bounameaux
H-Index: 45
Paolo Prandoni
H-Index: 8
Ahmed Mohamed
H-Index: 4
Ahmet Aksoy
H-Index: 27
Atsushi Kato
H-Index: 38
Azlan Husin
H-Index: 9
Chris Ward
H-Index: 29
Cynthia Wu
H-Index: 5
David Adler
H-Index: 1
David Jimenez
H-Index: 4
David Scott
H-Index: 2
Dirk Hagemann
H-Index: 27
Dmitry Petrov
H-Index: 5
Allosteric modulation of exosite 1 attenuates polyphosphate-catalyzed activation of factor XI by thrombin
Journal of Thrombosis and Haemostasis
2023/1/1
Rivaroxaban and apixaban are less effective than enoxaparin for the prevention of catheter-induced clotting in vitro
Journal of Thrombosis and Haemostasis
2023/1/1
PAR4 inhibition reduces coronary artery atherosclerosis and myocardial fibrosis in SR-B1/LDLR double knockout mice
Arteriosclerosis, thrombosis, and vascular biology
2023/11
Study of rivaroxaban for cerebral venous thrombosis: a randomized controlled feasibility trial comparing anticoagulation with rivaroxaban to standard-of-care in symptomatic …
Stroke
2023/11
OC 31.3 Phase 1 Study of the Safety, Tolerability, Pharmacokinetics, and Pharmacodynamics of VMX-C001 in Healthy Subjects
Research and Practice in Thrombosis and Haemostasis
2023/10/1
OC 45.5 The Lethality in Mice Treated with Intravenous Polyphosphate is Not Due to Thrombosis
Research and Practice in Thrombosis and Haemostasis
2023/10/1
New Therapeutic Targets for the Prevention and Treatment of Venous Thromboembolism With a Focus on Factor XI Inhibitors
2023/10
Warfarin faring better: Vitamin K antagonists beat rivaroxaban and apixaban in the INVICTUS and PROACT Xa trials
2023/7/8
Treatment of cancer-associated thrombosis: recent advances, unmet needs, and future direction
2023/7/1
Co-Authors
